Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$29.93 - $35.06 $1.14 Million - $1.34 Million
-38,238 Reduced 37.67%
63,269 $2.12 Million
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $1.95 Million - $3.43 Million
101,507 New
101,507 $3.28 Million
Q2 2023

Aug 14, 2023

BUY
$30.5 - $37.4 $1.22 Million - $1.49 Million
39,862 Added 87.09%
85,633 $3.01 Million
Q1 2023

May 15, 2023

SELL
$30.8 - $53.92 $2.8 Million - $4.9 Million
-90,838 Reduced 66.49%
45,771 $1.49 Million
Q4 2022

Feb 14, 2023

BUY
$45.4 - $60.91 $2.37 Million - $3.18 Million
52,223 Added 61.89%
136,609 $7.53 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $2.53 Million - $3.33 Million
60,069 Added 247.02%
84,386 $3.74 Million
Q2 2022

Aug 15, 2022

SELL
$33.54 - $52.15 $2.36 Million - $3.68 Million
-70,470 Reduced 74.35%
24,317 $1.19 Million
Q1 2022

May 16, 2022

BUY
$33.14 - $51.13 $1.72 Million - $2.65 Million
51,787 Added 120.43%
94,787 $4.61 Million
Q4 2021

Feb 14, 2022

SELL
$34.09 - $43.91 $396,568 - $510,805
-11,633 Reduced 21.29%
43,000 $1.83 Million
Q3 2021

Nov 15, 2021

BUY
$25.68 - $38.61 $897,438 - $1.35 Million
34,947 Added 177.52%
54,633 $2.09 Million
Q2 2021

Aug 16, 2021

BUY
$25.96 - $33.44 $511,048 - $658,299
19,686 New
19,686 $556,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.